Artificial intelligence and machine learning are launching a new era in drug development. By integrating these technologies, researchers can get their life-saving therapies to patients faster thanks to more accurate data and efficient processes.  

Join us as Brian Roche, General Manager of Charles River’s integrated toxicology site in Kansas, as he discusses the advantages of using these advanced technologies, how their being leveraged across multiple platforms, and what role they play in shaping the future.

Show Notes

New Integrated Toxicology Site 

Kansas Site 

Unlocking the Promise of Integrated Toxicology: A Tour Through the Lab of the Future 

Meeting at the Intersection of Technology and Scientific Innovation